Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pinedo

Showing results (11-20 of 569) with videos related to

Pageof 57
Sort By:
Clinical Breast Cancer|April 24, 2002
The role of vascular endothelial growth factor (VEGF) in tumor angiogenesis and early clinical development of VEGF-receptor kinase inhibitorsH M Verheul, H M Pinedo
Cancer|May 1, 1979
Partial remission of advanced adenoid cystic carcinoma obtained with adriamycin: a case report with a review of the literatureR J Vermeer, H M Pinedo
Cancer Drug Delivery|January 1, 1985
Cancer chemotherapy: alternative routes of drug administration. A reviewH J Keizer, H M Pinedo
Leukemia Research|January 1, 1982
Purine modulation of thymidine activity in L1210 leukemia cells in vitroA Leyva, H Appel, H M Pinedo
Nederlands Tijdschrift Voor Geneeskunde|August 12, 1999
[National cancer fund (Koningin Wilhelmina Fonds) justifiably calls for continued focus on the cancer problem in Netherlands]H M Pinedo, C J van Groeningen
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
Vascular endothelial growth factor and its inhibitorsH M W Verheul, H M Pinedo
Cancer Biochemistry Biophysics|September 1, 1984
Diverse deoxyribonucleotide profiles in cultured human cells with differential sensitivity to thymidineA Leyva, H Appel, H M Pinedo
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 1, 2003
Making use of the primary tumourArnold Baars, Jan Buter, Herbert M Pinedo
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1988
The main steps in the development of anticancer agentsG Schwartsmann, B Winograd, H M Pinedo
Nature Reviews. Cancer|May 25, 2007
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibitionHenk M W Verheul, Herbert M Pinedo
Pageof 57

Showing results (11-20 of 569) with videos related to

Sort By:
Pageof 57
Clinical Breast Cancer|April 24, 2002
The role of vascular endothelial growth factor (VEGF) in tumor angiogenesis and early clinical development of VEGF-receptor kinase inhibitorsH M Verheul, H M Pinedo
Cancer|May 1, 1979
Partial remission of advanced adenoid cystic carcinoma obtained with adriamycin: a case report with a review of the literatureR J Vermeer, H M Pinedo
Cancer Drug Delivery|January 1, 1985
Cancer chemotherapy: alternative routes of drug administration. A reviewH J Keizer, H M Pinedo
Leukemia Research|January 1, 1982
Purine modulation of thymidine activity in L1210 leukemia cells in vitroA Leyva, H Appel, H M Pinedo
Nederlands Tijdschrift Voor Geneeskunde|August 12, 1999
[National cancer fund (Koningin Wilhelmina Fonds) justifiably calls for continued focus on the cancer problem in Netherlands]H M Pinedo, C J van Groeningen
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
Vascular endothelial growth factor and its inhibitorsH M W Verheul, H M Pinedo
Cancer Biochemistry Biophysics|September 1, 1984
Diverse deoxyribonucleotide profiles in cultured human cells with differential sensitivity to thymidineA Leyva, H Appel, H M Pinedo
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 1, 2003
Making use of the primary tumourArnold Baars, Jan Buter, Herbert M Pinedo
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1988
The main steps in the development of anticancer agentsG Schwartsmann, B Winograd, H M Pinedo
Nature Reviews. Cancer|May 25, 2007
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibitionHenk M W Verheul, Herbert M Pinedo
Pageof 57